Orient Biotech
68829818.892.44% ( +0.45 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Orient Biotech(688298) the Revenue is 256.26 M (+33.5%);the EBIT is -74.35 M (+49.18%);the EPS is -0.49 (+14.04%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.26B33.50%
----
----
EBIT
-0.07B49.18%
----
----
EPS
-0.4914.04%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf